Topoisomerase II{alpha} amplification and anthracycline-based chemotherapy: the jury is still out.
Esteva
Francisco J
FJ
Hortobagyi
Gabriel N
GN
D018943:Anthracyclines / Q000191:economics / Q000627:therapeutic use*; D000951:Antigens, Neoplasm / Q000235:genetics / Q000378:metabolism*; D015415:Biomarkers / Q000378:metabolism*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D004250:DNA Topoisomerases, Type II / Q000235:genetics / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D018734:Genes, erbB-2 / Q000502:physiology*; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic
D018943:Anthracyclines; D000951:Antigens, Neoplasm; D015415:Biomarkers; D004268:DNA-Binding Proteins; D004250:DNA Topoisomerases, Type II